Technical Analysis for AHROQ - Atheronova Inc

Grade Last Price % Change Price Change
grade F 0.0015 -55.88% -0.0019
AHROQ closed down 55.88 percent on Friday, January 17, 2020, on 1 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical AHROQ trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Crossed Above 20 DMA Bullish -55.88%
MACD Bullish Signal Line Cross Bullish -55.88%
Narrow Range Bar Range Contraction -55.88%
Wide Bands Range Expansion -55.88%
Crossed Above 50 DMA Bullish -55.88%
Older signals for AHROQ ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


AtheroNova Inc. is a clinical-stage biopharmaceutical company. The Company through its subsidiary, AtheroNova Operations, Inc., is focused on the research and development of compounds to regress atherosclerotic plaque and improve lipid profiles in humans. The Company develops various applications for its compounds to be used for the treatment of atherosclerosis. The Company's development products include AHRO-001 and AHRO-002. The Company's pipeline candidates include applications for the treatment of localized reduction of subcutaneous fat deposits through transdermal application, obesity, hypertension, diabetes and Peripheral Artery Disease (PAD). The Company's lead compound is AHRO-001. Through the process of reverse cholesterol transport, the compound is designed to dissolve plaque within the walls of the arteries and removes it from the body through natural metabolic processes. AHRO-001 and AHRO-002 are orally administered compounds.
RTT Biopharmaceutical Diabetes Nutrition Hypertension Obesity Circulatory System Angiology Aging Associated Diseases Cardiovascular System Peripheral Artery Disease Vascular Diseases Cholesterol Atheroma Atherosclerosis Various Applications

Is AHROQ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 0.0583
52 Week Low 0.0005
Average Volume 17,045
200-Day Moving Average 0.0049
50-Day Moving Average 0.0032
20-Day Moving Average 0.0030
10-Day Moving Average 0.0022
Average True Range 0.0008
ADX 17.49
+DI 27.4336
-DI 45.1327
Chandelier Exit (Long, 3 ATRs ) 0.0046
Chandelier Exit (Short, 3 ATRs ) 0.0039
Upper Bollinger Band 0.0059
Lower Bollinger Band 0.0001
Percent B (%b) 0.24
BandWidth 193.3333
MACD Line -0.0004
MACD Signal Line -0.0003
MACD Histogram -0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0015
Resistance 3 (R3) 0.0015 0.0015 0.0015
Resistance 2 (R2) 0.0015 0.0015 0.0015 0.0015
Resistance 1 (R1) 0.0015 0.0015 0.0015 0.0015 0.0015
Pivot Point 0.0015 0.0015 0.0015 0.0015 0.0015
Support 1 (S1) 0.0015 0.0015 0.0015 0.0015 0.0015
Support 2 (S2) 0.0015 0.0015 0.0015 0.0015
Support 3 (S3) 0.0015 0.0015 0.0015
Support 4 (S4) 0.0015